SENSIENT TECHNOLOGIES CORP 4
4 · SENSIENT TECHNOLOGIES CORP · Filed Oct 29, 2013
Insider Transaction Report
Form 4
CLYDESDALE FERGUS M
Director
Transactions
- Sale
Common Stock
2013-10-28$52.89/sh−2,000$105,779→ 17,352.93 total - Exercise/Conversion
Stock Options (Right to Buy)
2013-10-28−2,000→ 0 totalExercise: $20.46From: 2005-05-03Exp: 2014-05-03→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2013-10-28$20.46/sh+2,000$40,920→ 19,352.93 total
Holdings
- 2,000
Stock Options (Right to Buy)
Exercise: $20.25From: 2007-05-01Exp: 2016-05-01→ Common Stock (2,000 underlying) - 2,000
Stock Options (Right to Buy)
Exercise: $30.07From: 2009-05-01Exp: 2018-05-01→ Common Stock (2,000 underlying) - 2,000
Stock Options (Right to Buy)
Exercise: $20.07From: 2006-05-02Exp: 2015-05-02→ Common Stock (2,000 underlying) - 2,000
Stock Options (Right to Buy)
Exercise: $26.12From: 2008-05-01Exp: 2017-05-01→ Common Stock (2,000 underlying)
Footnotes (4)
- [F1]Exercise of in-the-money stock option that would otherwise expire on 5/3/2014, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
- [F2]Includes shares of restricted stock held under Issuer's 2002 Non-Employee Director Stock Plan and 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan.
- [F3]This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $52.868 to $52.956. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.